Literature DB >> 16127213

Association of severe micropenis with Gly146Ala polymorphism in the gene for steroidogenic factor-1.

Yuka Wada1, Michiyo Okada, Tomonobu Hasegawa, Tsutomu Ogata.   

Abstract

Steroidogenic factor-1 (SF-1) regulates the transcription of multiple genes involved in the androgen biosynthesis, and SF-1 Gly146Ala polymorphism is known to reduce the transactivation function by approximately 20%. To examine whether the Gly146Ala polymorphism constitutes a susceptibility factor for the development of micropenis (MP), we analyzed this polymorphism in a total of 52 patients with micropenis (T-MP) consisting of 30 patients with severe MP below -2.5 SD (S-MP) and 22 patients with mild MP from -2.1 SD to -2.5 SD (M-MP), together with 115 control males. The Ala allele, the Ala/Gly genotype, and the Ala/Ala plus Ala/Gly genotype frequencies were significantly higher in the S-MP patients than in the control males, whereas the allele and the genotype frequencies were comparable between the M-MP patients and the control males. The results suggest that the SF-1 Gly146Ala polymorphism may constitute a susceptibility factor for the development of S-MP, and that M-MP can be regarded as a normal variation in terms of the polymorphism effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16127213     DOI: 10.1507/endocrj.52.445

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  8 in total

1.  Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function.

Authors:  Lin Lin; Pascal Philibert; Bruno Ferraz-de-Souza; Daniel Kelberman; Tessa Homfray; Assunta Albanese; Veruska Molini; Neil J Sebire; Silvia Einaudi; Gerard S Conway; Ieuan A Hughes; J Larry Jameson; Charles Sultan; Mehul T Dattani; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

2.  Isolated micropenis reveals partial androgen insensitivity syndrome confirmed by molecular analysis.

Authors:  Amrit Bhangoo; Francoise Paris; Pascal Philibert; Francoise Audran; Svetlana Ten; Charles Sultan
Journal:  Asian J Androl       Date:  2010-03-22       Impact factor: 3.285

Review 3.  Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development.

Authors:  L Lin; J C Achermann
Journal:  Sex Dev       Date:  2008-11-05       Impact factor: 1.824

4.  Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study.

Authors:  Pascal Philibert; Delphine Zenaty; Lin Lin; Sylvie Soskin; Françoise Audran; Juliane Léger; John C Achermann; Charles Sultan
Journal:  Hum Reprod       Date:  2007-10-16       Impact factor: 6.918

Review 5.  Steroidogenic factor-1 (SF-1, NR5A1) and human disease.

Authors:  Bruno Ferraz-de-Souza; Lin Lin; John C Achermann
Journal:  Mol Cell Endocrinol       Date:  2010-11-13       Impact factor: 4.102

6.  The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency.

Authors:  Birgit Köhler; Lin Lin; Inas Mazen; Cigdem Cetindag; Heike Biebermann; Ilker Akkurt; Rainer Rossi; Olaf Hiort; Annette Grüters; John C Achermann
Journal:  Eur J Endocrinol       Date:  2009-05-13       Impact factor: 6.664

7.  Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency.

Authors:  Birgit Köhler; Lin Lin; Bruno Ferraz-de-Souza; Peter Wieacker; Peter Heidemann; Vanessa Schröder; Heike Biebermann; Dirk Schnabel; Annette Grüters; John C Achermann
Journal:  Hum Mutat       Date:  2008-01       Impact factor: 4.878

8.  Functional characterization of novel NR5A1 variants reveals multiple complex roles in disorders of sex development.

Authors:  Gorjana Robevska; Jocelyn A van den Bergen; Thomas Ohnesorg; Stefanie Eggers; Chloe Hanna; Remko Hersmus; Elizabeth M Thompson; Anne Baxendale; Charles F Verge; Antony R Lafferty; Nanis S Marzuki; Ardy Santosa; Nurin A Listyasari; Stefan Riedl; Garry Warne; Leendert Looijenga; Sultana Faradz; Katie L Ayers; Andrew H Sinclair
Journal:  Hum Mutat       Date:  2017-11-02       Impact factor: 4.878

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.